Seed Therapeutics, Inc.

Importer · United States

Biotechnology, Molecular Glue Therapeutics, Targeted Protein Degradation

About Seed Therapeutics, Inc.

Seed Therapeutics, Inc. is a biotechnology company pioneering the development of molecular glue therapeutics aimed at degrading disease-causing proteins previously considered undruggable. Utilizing its proprietary RITE3SM platform, the company focuses on targeted protein degradation for the treatment of various diseases, including cancer, neurodegeneration, and infectious diseases. Seed Therapeutics collaborates with leading pharmaceutical companies and academic institutions to advance its innovative therapies. Seed Therapeutics, Inc. is a biotechnology company pioneering the development of molecular glue therapeutics aimed at degrading disease-causing proteins previously considered undruggable. Utilizing its proprietary RITE3SM platform, the company focuses on targeted protein degradation for the treatment of various diseases, including cancer, neurodegeneration, and infectious diseases. Seed Therapeutics collaborates with leading pharmaceutical companies and academic institutions to advance its innovative therapies. Company LinkedIn URL: https://www.linkedin.com/company/seed-therapeutics/